New hope for tough liver cancers: study tests two powerful drug combos
NCT ID NCT07340502
Summary
This study aims to find the best combination treatment for advanced liver cancer that cannot be removed by surgery. It will compare two different local drug delivery methods (TACE and HAIC), each combined with two other cancer drugs, in about 364 patients. The main goal is to see which combination better controls the cancer and helps patients live longer without their disease getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.